Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2025-06-13 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Telso" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
Director's Dealing Classification · 100% confidence The document text details a transaction notification involving a 'person discharging managerial responsibilities/person closely associated' ('Vesela Stoeva' associated with 'Sopharma' AD). It specifies the nature of the transaction ('Buy'), the financial instrument (Shares, ISIN № BG11SOSOBT18), and the price/volume details. This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2025-06-13 English
Notification of sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated 12.06.2025 concerning 'Treasury shares'. It explicitly states that the Company 'sold 6 200 (six thousand two hundred) repurchased own shares'. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The reference to Regulation (EU) No 596/2014 confirms it is a regulatory disclosure regarding share transactions.
2025-06-12 English
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Director's Dealing Classification · 100% confidence The document text contains structured tables detailing a transaction involving a 'person discharging managerial responsibilities' (Ognian Ivanov Donev) concerning shares of 'Sopharma AD'. Key fields like 'Reason for the notification' referencing Regulation 596/2014, 'Nature of the transaction' ('Buy'), and 'Description of the financial instrument' (Shares) are characteristic of insider trading disclosures required under EU market abuse regulations (MAR). This type of filing specifically reports personal share transactions by directors and executives. This matches the definition for Director's Dealing (DIRS).
2025-06-12 English
Notification from "Telso" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
Director's Dealing Classification · 100% confidence The document explicitly states in its header: "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". Furthermore, the content details the 'Details of the person discharging managerial responsibilities/person closely associated' and the 'Details of the transaction(s)', including the nature of the transaction ('Buy') and the price/volume. This directly corresponds to the definition of Director's Dealing (insider trades) filings.
2025-06-12 English
Notification of sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated June 11, 2025, specifically titled 'Treasury shares'. It details a transaction where the Company sold 21,413 repurchased own shares on June 10, 2025, and updates the total number of treasury shares held. This action directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is very short (713 chars), but it contains the substantive details of the transaction, not just an announcement that a report is available, making POS more specific than RPA or RNS.
2025-06-11 English
Notification from Bissera Lazarova in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
Director's Dealing Classification · 100% confidence The document details a transaction involving a 'person discharging managerial responsibilities' (Bissera Lazarova, a member of the Board of directors of Sopharma AD) regarding the purchase ('Buy') of company shares. This structure, focusing on personal share transactions by directors and executives, directly aligns with the definition of Director's Dealing reports, which are typically mandated by regulations like MAR (Market Abuse Regulation) in the EU, corresponding to the code DIRS.
2025-06-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.